Nuvation Bio Inc. Class A (NUVB) Key Ratios

$6.64

up-down-arrow $-0.02 (-0.30%)

As on 01-Sep-2026 16:20EDT

Market cap

info icon

$2,398 Mln

Revenue (TTM)

info icon

$170 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

10

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -61.93 555.64 1,083.56 862.45 --
EBIT -563.29 4.28 36.11 -17.03 -55.98
Net Profit -1,264.35 -6.50 26.16 -30.01 -180.56
EPS -1,360.32 -4.05 30.69 -1.76 -4.17
Book Value -- -- -35.50 -33.35 -11.22
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -3,756.49-3,756.49-76.04-303.56-7,209.42
Net Margin info ---990.33-88.19----
Return on equity info -57.16-40.89-53.55-53.18-106.27
Return on Capital info -56.28-40.33---51.90-105.00
Return on Assets info -48.50-35.46-19.40-36.04-97.74
Debt to Equity (x) info ----0.960.030.02
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
-51.90
-105.00
-11.95
-14.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-53.55

Lower than Peers by 13.15

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-53.55
-53.18
-106.27
-12.03
-14.87
Peer Median
-40.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-19.40

Higher than Peers by 11.58

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-19.40
-36.04
-97.74
-11.72
-14.39
Peer Median
-30.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-76.04

Higher than Peers by 7.58

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-76.04
-303.56
-7,209.42
--
--
Peer Median
-83.62
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-88.19

Higher than Peers by 4.48

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-88.19
-325.31
-7,213.76
--
-670.74
Peer Median
-92.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

1,083.56

Higher than Peers by 1,029.61

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
1,083.56
6.99
--
--
--
Peer Median
53.95
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

36.11

Higher than Peers by 36.91

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
36.11
66.36
-648.79
27.25
-19.98
Peer Median
-0.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

26.16

Higher than Peers by 33.46

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
26.16
63.97
-649.24
27.25
-19.98
Peer Median
-7.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

30.69

Higher than Peers by 16.04

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
30.69
0.65
-3.87
0.27
-0.11
Peer Median
14.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-33.49

Lower than Peers by 23.31

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-33.49
--
--
--
--
Peer Median
-10.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.96

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
0.96
0.03
0.02
0.01
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
0.03
0.02
0.02
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

8.37

Higher than Peers by 2.56

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
8.37
6.95
9.04
44.11
50.70
Peer Median
5.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

8.14

Higher than Peers by 2.45

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
8.14
6.81
9.04
--
--
Peer Median
5.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-4.62

Lower than Peers by 2.53

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
-4.62
-13.96
-1,664.51
--
-11.38
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

18.67

Lower than Peers by 0.47

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
18.67
30.78
206.94
--
--
Peer Median
19.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.22

Higher than Peers by 0.16

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
0.22
0.11
0.01
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
103.51
463.79
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
246.85
--
--
485,302.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
342.38
220.79
3,576.82
2,288.10
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
7.98
243.00
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
-15.08
-1.58
-4.36
-4.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

10.04

Higher than Peers by 4.86

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
10.04
10.09
1.93
0.55
0.64
Peer Median
5.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

2.23

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
2.23
-13.56
-0.71
3.66
2.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

2,398

Higher than Peers by 2,252

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Nuvation Bio Inc. Class A (NUVB)
2,398
--
--
--
--
Peer Median
146
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...